In vivo regulation of M. tuberculosis cell wall lipids
In vivo regulation of M. tuberculosis cell wall lipids
批准号:
7895606
负责人:
LEE W RILEY
金额:
$37.77万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-17 至 2012-06-30
关键词:
Acquired Immunodeficiency SyndromeAffectAmericanApoptoticAttenuatedBacillus (bacterium)Cell WallCellsClinicalEnvironmentEquilibriumFamilyFundingGenesGoalsGranulomaHIV InfectionsHigh PrevalenceImmunocompetentInfectionInflammationLeadLipidsLungMediatingMusMutant Strains MiceMycobacterium tuberculosisOperonOutcomePathogenicityPhenotypePlayProteinsRecoveryRegulationRoleSignal TransductionSurfaceSystemTestingTuberculosisabstractingbasecell envelopein vivolipid transportmembermutantresponsetuberculosis granuloma
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This is a revised abstract of an application of a proposal being considered for funding
through the American Recovery and Reinvestment Act. The goal of this project is to
characterize the role of an M. tuberculosis operon called mcel associated with latent TB
infection. This project is based on a new hypothesis that M. tuberculosis needs to
readapt to the constantly changing environment of the host granulomatous lesion in
which the bacilli reside. We have evidence that this intra-granuloma adaptation is
mediated by M. tuberculosis remodeling its cell envelope in response to signals
produced by apoptotic cells. We propose that this remodeling is regulated by the mcel
operon of M. tuberculosis. Previous studies have shown that an M. tuberculosis strain
disrupted in the mcel operon becomes hypervirulent in mice and is unable to elaborate
organized granulomas in mouse lungs. An M. tuberculosis strain disrupted in the
negative regulator of this operon called mcel R is also hypervirulent in mice. With the
former mutant, mouse dies because of uncontrolled bacterial proliferation while with the
latter, the mouse dies because of uncontrolled inflammation. Thus, these two extreme
granuloma-related clinical outcomes in immunocompetent mice are induced simply by
affecting the expression of the mcel operon genes. This suggests that this operon plays
a homeostatic role in response to granuloma formation. M. tuberculosis contains 3 other
members of this mce operon called mce2, 3, and 4. The mce3 and mce4 mutants have
been tested in mice, and they show a phenotype distinct from that of the mcel operon
mutant--they are attenuated in mice. Thus, the functions of the 4 mce operons may
vary, but they may also be related. The specific aim of this project for the revised 2-year
project is to characterize the function of the mcel operon as a possible lipid transport
system or regulator and how this may contribute to remodeling M. tuberculosis cell
envelope in response to granuloma cell turnover for the bacillus to establish infection.
The previous additional aim to characterize the relationship of the mcel operon to mce2,
3, and 4 operons will be done under a support mechanism to which we plan to apply in
Yr 2 of this project. We believe this characterization of the relationship between M.
tuberculosis and granulomas may contribute to our understanding of the mechanism of
persistence of M. tuberculosis that could lead to new tests to differentiate active TB from
latent TB infection.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
-
批准号:9515095
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2017
-
负责人:LEE W RILEY
-
依托单位:
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
-
批准号:10012954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:LEE W RILEY
-
依托单位:
Framework to Address Drug Resistant Infections and Global Health
-
批准号:8051295
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2010
-
负责人:LEE W RILEY
-
依托单位:
In vivo regulation of M. tuberculosis cell wall lipids
-
批准号:7420965
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2009
-
负责人:LEE W RILEY
-
依托单位:
Therapeutic vaccine against tuberculosis
-
批准号:7086309
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2005
-
负责人:LEE W RILEY
-
依托单位:
Therapeutic vaccine against tuberculosis
-
批准号:6857558
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2005
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:6986122
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:7151208
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:7325684
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:6864942
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:8051680
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:7802207
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7048697
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7028684
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:6701223
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7217962
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:6799670
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:7668488
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:8240438
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Epidemiology of an uropathogenic E coli clonal group
-
批准号:6662001
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:LEE W RILEY
-
依托单位:
海外基金